Videra Health Named to MountainWest Capital Network’s 2025 Utah 100 Emerging Elite

Videra Health Logo

Orem, UT, October 17, 2025 – Videra Health, a leading AI platform for behavioral health providers, today announced it was named to the 2025 Utah 100 Emerging Elite category, MountainWest Capital Network (MWCN)’s annual list of the fastest-growing companies in Utah.
Videra Health was honored at the 31st annual Utah 100 Awards program, held at the Grand America Hotel in Salt Lake City.

“We’re honored to be recognized among Utah’s Emerging Elite,” said Loren Larsen, CEO of Videra Health. “Utah’s innovation community has helped to fuel our growth and mission to make behavioral healthcare more proactive, accessible, and effective through AI. This
recognition affirms our commitment to improving patient outcomes and advancing care both locally and nationwide.”

“We congratulate all of this year’s Utah 100 companies for building outstanding businesses and making strong contributions to Utah’s economy,” said Chris Badger, Chairman of the MWCN Utah 100 committee. “These companies further advance Utah’s standing as an excellent place to do business.”

Recipients of the Utah 100 Emerging Elite were chosen as a Utah business with great prospects for future growth and success.

Videra Health’s rapid growth reflects its unique approach to behavioral healthcare, combining AI-driven insights with real-world clinical applications. The company has expanded its platform to serve a growing network of providers, helping them identify at-risk patients, optimize care workflows, and improve outcomes. By generating actionable patient data and insights at scale, Videra Health also creates opportunities for healthcare and pharmaceutical partners to better understand treatment patterns, support clinical decision-making, and enhance patient engagement. These measurable achievements align with the Utah 100 Emerging Elite’s focus on recognizing companies with strong growth potential and market impact.

Videra Health team at t he Utah 100 2025 Awards Event
From left to right, members of the Videra Health team: Brad Grimm, Madeline Cheney, Byron Clark, William Burk, Brett Talbot, Mike Henneman, Mel Walker, and Sterling Mason.

About MountainWest Capital Network

MountainWest Capital Network (MWCN) is the largest business networking organization in Utah, consisting of entrepreneurs, venture capitalists, consultants, legal professionals, bankers, and educators. MWCN seeks to promote and recognize business growth and capital development in the state through a variety of award programs and activities.

About Videra Health™

Videra Health is a leading AI platform for behavioral health providers and proactively identifies, triages and monitors at-risk patients using linguistic, audio and video analysis. The FDA-registered digital platform transforms how doctors and healthcare systems interact and track a patient’s journey, illuminating the hidden depths of patient behavior and outcomes. Videra Health connects providers and patients anytime, anywhere, between visits and post-discharge via written and video assessments that translate into actionable quantitative and qualitative patient data. The platform streamlines diagnoses, enhances care accessibility, optimizes workflows and drives down costs for providers and healthcare systems.

Videra Health Launches “Check on Mom,” the First Free AI-Powered Postpartum Depression Screener

Videra Health Logo

New initiative empowers moms with a confidential, stigma-free video screener for postpartum depression, powered by conversational AI

Orem, UT, September 23, 2025 – Videra Health, a leading AI platform for behavioral health providers, today announced the launch of Check on Mom, the first free, confidential AI-powered postpartum depression screener. The self-assessment tool empowers mothers to complete a private, video-based check-in using conversational AI that captures both verbal and non-verbal signs of postpartum depression (PPD) and generates results they can share with a provider.

Unlike traditional written screeners, Check on Mom uses video and AI language models trained specifically for healthcare to analyze both spoken words and non-verbal cues. This dual-layer approach provides deeper insights into maternal mental health, making it easier to distinguish between common “baby blues” and postpartum depression.

“Check on Mom is not just a digital tool, it is a public health resource,” said Loren Larsen, co-founder and CEO of Videra Health. “By showing what is possible with AI-powered video screeners, we are opening new opportunities for earlier detection and better outcomes, not just in maternal health but across conditions where timely screening can make a real difference for patients and providers.”

How Check on Mom Works:

  • Free and confidential: No insurance, no cost.
  • Fast and convenient: Completed on almost any device, at any time, in less than three minutes.
  • Video-based and shame-free: Instead of static surveys, moms can speak openly and naturally about how they feel, and results are theirs to share
  • Clinically validated insights: Downloadable results can be shared with OBs, midwives, or primary care providers to guide next steps.

One in eight mothers experience postpartum depression, yet most go undiagnosed or untreated because screenings are inconsistent, stigma persists, and support often arrives too late. With Check on Mom, any mother can complete a short, video-based screener in just a few minutes and access secure results immediately without waiting for a six-week appointment or navigating health system barriers.

Check on Mom is more than a consumer resource. It is a proof point for how AI can transform condition-specific screening at scale. By applying conversational AI and video analysis, Videra Health is creating earlier pathways to care for conditions that are too often overlooked.

In addition to proprietary AI models already used to screen for depression, anxiety, trauma, and other conditions, the company most recently released TDScreen, the first AI-powered screener for tardive dyskinesia. These tools show how AI screeners can:

  • Expand access to early detection in underserved populations.
  • Deliver patient-centered insights that improve diagnosis and treatment.
  • Provide adaptable, condition-specific screening models that can be applied across therapeutic areas.

Across healthcare from patients and providers to pharma leaders, Check on Mom demonstrates how technology can expand access to postpartum depression screening, improve early detection, and support better patient outcomes. Videra is working to normalize maternal mental health conversations and demonstrate a new model for patient-first innovation.

Check on Mom is available free of charge for any mom wanting to screen for postpartum depression. Visit www.checkonmom.ai to learn more.

About Videra Health™

Videra Health is a leading AI platform for behavioral health providers and proactively identifies, triages and monitors at-risk patients using linguistic, audio and video analysis. The FDA-registered digital platform transforms how doctors and healthcare systems interact and track a patient’s journey, illuminating the hidden depths of patient behavior and outcomes. Videra Health connects providers and patients anytime, anywhere, between visits and post-discharge via written and video assessments that translate into actionable quantitative and qualitative patient data. The platform streamlines diagnoses, enhances care accessibility, optimizes workflows and drives down costs for providers and healthcare systems.

Videra Health Launches TDScreen, a First-of-Its-Kind Video-based, AI-powered Tool to Assess Tardive Dyskinesia Symptoms

Videra Health Logo

New study published in the Journal of Clinical Psychiatry reveals AI enables efficient, accurate and scalable detection of TD, representing a significant advancement in meeting the standard of care for TD screening

Orem, UT, June 3, 2025 – Videra Health, a leading AI platform for behavioral health providers, has announced the launch of TDScreen, the first-ever automated, video-based AI solution on the market to screen for Tardive Dyskinesia (TD) symptoms. TD is a chronic, involuntary movement disorder that can develop as a side effect of long-term use of certain medications, particularly antipsychotic drugs. While TDScreen isn’t intended as a standalone diagnostic tool, it represents a significant advancement in meeting the standard of care for TD screening.

TD presents unique screening challenges even for experienced clinicians and remains underdiagnosed. TD affects up to 2.6 million Americans, and up to 7 million Americans taking antipsychotic medications could develop TD symptoms. With its involuntary movements often mistaken for nervousness, aging, or other conditions, the gap in recognition represents not just a clinical challenge, but a deeply human one that affects quality of life and treatment outcomes. A paper published Wednesday in The Journal of Clinical Psychiatry, led by Principal Investigator Dr. Anthony Sterns and members of the iRxReminder and Videra Health teams, reveals that video-based AI enables efficient, accurate, and scalable detection of TD. This application has the potential to significantly improve early diagnosis and patient outcomes, especially in remote care settings where resources are scarcest. Videra Health’s TDScreen algorithm was built using the data from multiple studies, which was supported in part by the National Institute of Mental Health, and represents a significant leap forward in integrating artificial intelligence into psychiatric care, particularly in the era of telemedicine.

“Videra Health is thrilled to be able to launch a first-of-its-kind innovative solution to screen for TD symptoms, effectively,” said Loren Larsen, CEO of Videra Health. “TDScreen and our broader AI platform aren’t about replacing clinician judgment—they’re about enhancing it. By automating routine screenings, we free healthcare providers to focus on what matters most: the human connections and complex decision-making that drive quality care.” Larsen added, “We are grateful for the multiple academic and research partners who have contributed their time and expertise to these studies.”

“Early detection of TD is critical to mitigating its debilitating effects,” said Dr. Anthony A. Sterns, Ph.D., lead researcher on the project and CEO at iRxReminder. “Our AI-driven approach not only matches but exceeds human expert performance, offering a scalable solution to a major unmet clinical need,” added Dr. Joel W. Hughes, Ph.D., collaborator from Kent State University.

“As a physician who both treats –and lives with– tardive dyskinesia, this research marks a turning point for millions of patients who have been forced to wonder if the movement disorder they suffer from could be treatable,” says Owen S, Muir, M.D., CMO of iRxReminder, CMO and co-founder of Radial Health, and co-author of the publication.  “Now, physicians have a simple, evidence-based AI-guided tool to support their clinical decision making.”

TDScreen was validated across three clinical studies involving more than 350 participants on antipsychotic medications. The innovative AI tool developed by Videra Health utilizes advanced video analysis and a vision transformer machine learning architecture to detect TD with unprecedented accuracy. TDScreen demonstrates a Cohen’s Kappa of 0.61—a number indicating the algorithm is outperforming even calibrated human raters. The algorithm achieved an area under the receiver-operating-characteristic curve (AUC) of 0.89, surpassing the sensitivity and specificity of trained human raters using the standard Abnormal Involuntary Movement Scale (AIMS).

These numbers represent more than just statistical achievements—they translate to real-world benefits:

  • Consistency: Unlike human raters whose assessments may vary, AI provides the same evaluation standards every time
  • Accessibility: Patients can complete assessments from home on their own devices
  • Efficiency: Providers save valuable clinical time while increasing screening frequency
  • Earlier detection: Subtle symptoms can be identified before they become pronounced

Continuous monitoring: Regular assessments track symptom progression or improvement

With TDScreen, patients on antipsychotics can easily complete video-based screenings in-office or remotely, and enable providers to monitor or modify their treatment plans. The TDScreen tool is based on the Abnormal Involuntary Movement Scale (AIMS), a comprehensive clinician-rated scale designed to specifically evaluate involuntary movements. Employing advanced AI video technology, TDScreen efficiently assesses and quantifies the risk of TD in less than 5 minutes. The resulting score generated by this assessment can aid in clinical decision-making and management strategies.

TDscreen is available free of charge for any provider or patient wanting to screen for TD. Visit tdscreen.ai to learn more.

About Videra Health™

Videra Health is a leading AI platform for behavioral health providers and proactively identifies, triages and monitors at-risk patients using linguistic, audio and video analysis. The FDA-registered digital platform transforms how doctors and healthcare systems interact and track a patient’s journey, illuminating the hidden depths of patient behavior and outcomes. Videra Health connects providers and patients anytime, anywhere, between visits and post-discharge via written and video assessments that translate into actionable quantitative and qualitative patient data. The platform streamlines diagnoses, enhances care accessibility, optimizes workflows and drives down costs for providers and healthcare systems. 

For more information, visit www.viderahealth.com.

About iRxReminder
iRxReminder specializes in digital health solutions aimed at enhancing medication adherence and mental health management through cutting-edge technology applications and innovative behavioral science solutions.

For more information, visit www.irxreminder.com.

Introducing Sidekick Notes and Our Complete Sidekick Suite – Transforming Healthcare Documentation

Sidekick Notes and Elevate

Today marks a significant milestone in our journey to revolutionize healthcare workflows. I’m thrilled to announce the launch of our newest innovation: Sidekick – our comprehensive AI-powered solution designed to transform how healthcare professionals create, manage, and derive insights from clinical documentation.

The Challenge We're Solving

For years, we’ve heard from our healthcare partners about the overwhelming administrative burden that pulls providers away from what matters most – patient care. Documentation requirements have steadily increased, forcing clinicians to spend hours each day on paperwork rather than with patients. This documentation burden is a leading contributor to provider burnout and diminished patient experience.

At Videra Health, we believe technology should serve healthcare professionals, not the other way around. That’s why we’ve developed Sidekick.

Introducing the Sidekick Suite

Sidekick is our powerful AI-fueled notetaking technology that allows providers to generate detailed clinical documentation from a wide array of sessions, meetings, and patient interactions. By automating and streamlining the note-taking process, Sidekick enables accurate and comprehensive records without the burden of manual entry.

Our comprehensive Sidekick suite includes two powerful components:

Sidekick Notes

This is the breakthrough that many of you have been waiting for! Sidekick Notes generates comprehensive clinical documentation in multiple formats to suit your specific needs:

  • Speaker Map: Sidekick Notes automatically identifies each speaker throughout the session transcript, eliminating the tedious task that other tools require — providers manually labelling each speaker in the notes after the session ends.
  • Multiple Note Formats: Choose between SOAP, DAP, and GIRP note formats
  • Customizable Tone: Select standard progress notes or medical necessity documentation
  • Configurable Patient Information: Tailor required fields based on your practice requirements
  • Enhanced Dictation: Automatically expands abbreviated notes into comprehensive documentation, revealing critical clinical data to improve diagnosis and treatment decisions.
  • Edit & Regenerate: Manually edit or regenerate notes for complete control
  • Chrome Extension: Generate notes directly from your browser
  • Zoom Integration: Automatically capture notes through our dedicated Zoom app
  • Portal Recording: Initiate notes directly from the Videra provider portal
  • Live Session Creation: Create blank sessions to capture notes later

Sidekick Elevate

Sidekick Elevate analyzes clinical sessions to provide actionable metrics that can help improve patient care:

  • Provider/Patient Alignment: Track speech rate, question frequency, emotional mirroring, sentiment, speaking overlaps, and communication style
  • Key Moments: Instantly surfaces critical insights on emotional states and reactions not captured in notes, ensuring no vital information is missed.  
  • Quality Metrics: Measures empathy, teachback effectiveness, and trust-building
  • Visual Representations: See speaking patterns and distribution of time between provider and patient
  • Language Analysis: Break down pronoun and verb tense usage for participants

The Impact

Organizations implementing Sidekick will experience:

  • Reduced Administrative Fatigue: Free up valuable time previously spent on documentation
  • Enhanced Efficiency: See more patients while maintaining or improving documentation quality
  • Improved Workflow: Streamline the entire clinical documentation process
  • Consistent Documentation: Reduce the risk of missing critical details due to human error

Most importantly, patients benefit from providers who are more present, engaged, and able to dedicate more time to personalized care, ultimately leading to better treatment outcomes.

Available Now

I’m pleased to announce that the entire Sidekick suite is available today for all Videra Health customers. To implement Sidekick in your practice or learn more about specific features, please complete our interest form. Our team will contact you with all the details – demos, pricing and implementation process.

Not a Videra customer yet? What are you waiting for? Notes are just the beginning. Get a demo here, and see all the things Videra can do for you.

At Videra Health, we remain committed to developing innovative solutions that empower healthcare providers to deliver exceptional care. Sidekick represents a significant step forward in that mission, and I couldn’t be more excited to share it with you today.

Here’s to a future where technology enhances the human connection in healthcare, rather than diminishing it.

Check our blog for the latest discussions on AI in healthcare, behavioral health, life sciences and clinical trials.

Improving Intake Processes Without Overloading Staff: Technology’s Role in Patient Flow

As healthcare providers, we all share a common challenge: efficiently managing the automated healthcare intake process while maintaining quality care and not overwhelming our already stretched staff. Whether you’re running a behavioral health clinic or coordinating clinical trials, intake processes often create bottlenecks that impact everything downstream.

The Automated Healthcare Intake Revolution

The statistics tell a sobering story. Traditional intake assessments typically require 30-60 minutes of clinical time per patient, with staff spending additional hours on documentation and coordination. For many behavioral health organizations, this translates to:

  • Extended wait times averaging 3+ months for new patient appointments
  • High no-show rates (often exceeding 30%) due to delayed access
  • Significant administrative burden leading to clinician burnout
  • Lost revenue from unfilled appointments and incomplete assessments

Clinical trial administrators face similar challenges, with participant screening and enrollment often consuming 30% of total study costs and extending timelines by months.

How Our Automated Healthcare Intake Process Works

At Videra Health, we’ve focused on developing solutions that specifically address these intake challenges while preserving what matters most – the human connection between providers and patients.

Our Videra Intake Manager transforms the traditional intake process by combining AI-driven automation with thoughtful human design. This system allows patients to complete comprehensive assessments on their own time while automatically generating the documentation your team needs.

Key capabilities include:

  • Automated pre-screening that identifies appropriate level of care before the first appointment
  • Self-directed video assessments that capture rich clinical information without provider time
  • AI-assisted documentation that generates structured intake reports
  • Seamless EHR integration that eliminates duplicate data entry
  • Multi-language support that expands access to diverse populations

Real Results from Real Implementations

Behavioral health organizations implementing our intake solutions have reported impressive outcomes:

  • 50% reduction in administrative time spent on new patient processing
  • 35% increase in completed intake appointments
  • 28% decrease in time-to-treatment for new patients
  • 42% improvement in staff satisfaction with intake processes

For clinical trial administrators, our system has demonstrated:

  • 40% faster participant screening and enrollment
  • 65% reduction in administrative processing time
  • 30% improvement in protocol adherence during screening
  • Significant enhancement in participant diversity through expanded access

A Practical Implementation Approach

The most successful implementations we’ve seen take a phased approach. Rather than completely overhauling existing processes, many organizations begin by implementing Videra Assess for pre-appointment screening, then gradually integrate more automation as staff and patients become comfortable with the technology.

This measured approach ensures that technology enhances rather than disrupts your care delivery model, with each phase building on previous successes.

Looking Forward: The Integrated Intake Ecosystem

The future of intake management lies in seamless integration between automated assessment tools, documentation systems, and advanced operational tools.

Together, these create an ecosystem that not only improves efficiency but actually enhances the quality of clinical information gathered during the intake process.

To learn more about how Videra Health can transform your intake processes, schedule a personalized demonstration with our team.

Your patients deserve prompt access to care, and your staff deserves technology that makes their jobs easier rather than more complicated. Let’s work together to make that a reality.

Check our blog for the latest discussions on AI in healthcare, behavioral health, life sciences and clinical trials.

5 Ways AI Can Help Mental Health Clinicians Manage a Growing Caseload

As mental health providers face mounting caseloads and rising demand, AI offers a path forward by enhancing efficiency without sacrificing personalized care. This article highlights how AI-powered screening platforms, rooted in measurement-based care, are helping clinicians prioritize high-risk patients, automate routine tasks, and extend their reach beyond the office. The result is more time for meaningful client interactions and stronger therapeutic relationships—hallmarks of quality care. With the right implementation, AI serves not as a replacement, but as a trusted partner in the delivery of smarter, more responsive mental health services.
Read the full article here.

How AI is Empowering Providers with Early Detection of Mental Illness

AI is transforming mental health care by enabling earlier, more precise detection of symptoms that might otherwise go unnoticed until crisis points. This thoughtful piece explores how technology can continuously monitor subtle behavioral shifts—augmenting clinical expertise and allowing providers to intervene sooner. By analyzing data across multiple modalities and comparing patients to their own baselines, AI supports a shift from reactive treatment to proactive care. The result is better outcomes, lower costs, and a future where clinicians are empowered—not replaced—by intelligent tools.
Read the full article here.

Meet The Disruptors: Loren Larsen Of Videra Health On The Five Things You Need To Shake Up Your Industry

Loren Larsen, CEO of Videra Health, shares his perspective on what it takes to truly disrupt an industry in this thoughtful Authority Magazine interview. Drawing on decades of experience in healthcare technology and AI, Larsen reflects on the challenges of innovating in a highly regulated, human-centered field like mental health. He discusses how Videra Health is leveraging video-based AI to enhance early detection and support clinicians without replacing the essential human connection. Throughout the piece, he emphasizes the importance of trust, empathy, and deep domain expertise in building solutions that actually move the needle.

Read the full article here.

Trust and Transformation Take Center Stage at DataRobot’s 2021 AI Experience Worldwide, May 11-12, 2021

Videra Health Logo

Tech visionary Alexis Ohanian and newly appointed CEO of DataRobot, Dan Wright, join customers, execs, partners, and AI visionaries on “The Hunt for Transformational Growth” during virtual event

BOSTON–(BUSINESS WIRE)–DataRobot, the leader in enterprise AI, is on “The Hunt For Transformational Growth” with its second annual virtual event on May 11-12. Alexis Ohanian, Founder of Seven Seven Six and Co-Founder of Reddit, and America’s “Science Guy,” Bill Nye, join a dynamic speaker line-up, including DataRobot executives and customers, business leaders, data scientists, educators, and leading AI ethicists. The two-day event is open to the public and free to attend, with sessions available on-demand immediately following.

Competition is fierce these days and organizations must scale fast, smart, and efficient. Offering over 20 sessions from unique voices in business and AI, AI Experience Worldwide attendees will gain actionable insight on building an agile, AI-driven enterprise and access to cutting-edge strategy that is critical when it comes to improving forecasts and optimizing performance with AI.

Day 1 of the conference includes a forward-leaning conversation featuring DataRobot’s CEO, Dan Wright, on his call for a new era of democratized AI, as well as a sneak peek at some of DataRobot’s enterprise AI platform innovations from Nenshad Bardoliwalla, SVP of Product. Executives from Yelp, Overstock.com, Pendo, and Airin share unscripted insight on their path to transformational growth.

Day 2 explores why trust in AI is no longer a feature, it’s a requirement. DataRobot’s Global AI Ethicist, Haniyeh Mahmoudian, PhD, will address the skepticism surrounding AI solutions, and discuss why it’s critical to approach issues of bias and fairness by implementing trustworthy AI.

Additional highlights include:

  • Opening Keynote from tech visionary Alexis Ohanian, Founder of Seven Seven Six and Co-Founder of Reddit. This session will explore Alexis’s views on the future of tech and how he intends to enable a better world for the next generation.
  • Ricky Ray Butler, CEO of BEN Group, Linda Klug, Founder & CEO of Airin, and Loren Larsen, CEO/Co-Founder of Videra Health, join DataRobot Chief AI Evangelist, Ben Taylor, for a transparent conversation around their initial doubts—and ultimate takeaways—when implementing AI to transform their business.
  • Sally Embrey, DataRobot’s VP of Public Health and Medical Technologies, speaks to the pivotal role of data and AI as we seek to democratize health, empower patients, and allow individuals to thrive.
  • Closing remarks from “Science Guy” Bill Nye and Chris Mattmann, Chief Technology and Innovation Officer at NASA Jet Propulsion Laboratory, on the importance of research and discovery, fighting anti-science sentiment, space exploration, where humanity is headed, and how we can all play a role.

“Every company is now an AI company, and the decision to implement AI is no longer optional,” said Wright. “Knowing this, we’re excited to welcome technologists, corporate leaders, data scientists, researchers, and users at every level to witness the transformational potential of AI on businesses’ bottom line. Our goal is to create a space for transparent discussions around the complexities surrounding AI. We’ll have CEOs share their own hesitations when embracing AI and AI ethicists and educators explore the need for AI we can trust, with actionable roadmaps to help us plan for and handle institutional bias as we look to the future.”

To register for DataRobot’s virtual conference or to learn more about the event, visit the AI Experience Worldwide website and follow along on Twitter #AIExperience.

About DataRobot

DataRobot is the leader in enterprise AI, delivering trusted AI technology and enablement services to global enterprises competing in today’s Intelligence Revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. This platform maximizes business value by delivering AI at scale and continuously optimizing performance over time. The company’s proven combination of cutting-edge software and world-class AI implementation, training, and support services, empowers any organization – regardless of size, industry, or resources – to drive better business outcomes with AI.

DataRobot has offices across the globe and funding from some of the world’s best investing firms including Alliance Bernstein, Altimeter, B Capital Group, Cisco, Citi Ventures, ClearBridge, DFJ Growth, Geodesic Capital, Glynn Capital, Intel Capital, Meritech, NEA, Salesforce Ventures, Sands Capital, Sapphire Ventures, Silver Lake Waterman, Snowflake Ventures, Tiger Global, T. Rowe Price, and World Innovation Lab. DataRobot was named to the Forbes 2020 Cloud 100 list and the Forbes 2019, 2020, and 2021 Most Promising AI Companies lists, and was named a Leader in the IDC MarketScape: Worldwide Advanced Machine Learning Software Platforms Vendor Assessment. For more information visit http://www.datarobot.com/, and join the conversation on the DataRobot Community, More Intelligent Tomorrow podcast, Twitter, and LinkedIn.